0001570562-23-000104.txt : 20230823
0001570562-23-000104.hdr.sgml : 20230823
20230823200707
ACCESSION NUMBER: 0001570562-23-000104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230821
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yamagishi-Dressler Tomoko
CENTRAL INDEX KEY: 0001990968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 231198709
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE, SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
wk-form4_1692835617.xml
FORM 4
X0508
4
2023-08-21
0
0001570562
Evolus, Inc.
EOLS
0001990968
Yamagishi-Dressler Tomoko
520 NEWPORT CENTER DRIVE
SUITE 1200
NEWPORT BEACH
CA
92660
0
1
0
0
Chief Marketing Officer
0
Common Stock
2023-08-21
4
A
0
63358
0
A
63358
D
Stock Option (Right to Buy)
9.40
2023-08-21
4
A
0
83555
0
A
2033-08-21
Common Stock
83555
83555
D
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
/s/ Jeffrey J. Plumer, as attorney-in-fact for Tomoko Yamagishi-Dressler
2023-08-23